Skip to main content

Table 1 Clinical and laboratory characteristics before and after ALA treatment

From: α-Linolenic acid increases the G0/G1 switch gene 2 mRNA expression in peripheral blood mononuclear cells from obese patients: a pilot study

Parameters Baseline   After 12 weeks  
ALA (n = 14) Control (n = 12) p ALA (n = 14) Control (n = 12) p
Age (years) 48.6 ± 6.8 49.3 ± 4.8 0.775    
Body weight (kg) 93.6 ± 6.6 95.3 ± 6.6 0.329 89.8 ± 5.8 92.6 ± 6.7 0.265
BMI (kg/m2) 32.3 ± 1.2 32.7 ± 1.0 0.331 31.0 ± 1.3 31.8 ± 0.8 0.076
TC (mmol/L) 5.01 ± 0.48 5.17 ± 0.45 0.418 4.79 ± 0.42 5.01 ± 0.41 0.203
TG (mmol/L) 3.59 ± 0.65 3.73 ± 0.63 0.565 1.73 ± 0.31 2.63 ± 0.54 <0.0001*
FFA (μmol/L) 655 ± 324 662 ± 28 0.516 469 ± 29 501 ± 28 0.009*
Glycerol (μmol/L) 1505 ± 27 1538 ± 83 0.183 1028 ± 82 1201 ± 94 0.046*
IL-6 (ng/L) 2.34 ± 0.14 2.37 ± 0.15 0.603 1.53 ± 0.14 1.87 ± 0.12 <0.0001*
TNF-α (ng/L) 1.92 ± 0.14 1.92 ± 0.16 0.981 1.28 ± 0.10 1.63 ± 0.15 <0.0001*
  1. Data are means ± SD
  2. ALA vs Control, two-sample t test, *p < 0.05